NCT00792558View on ClinicalTrials.gov

Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Advanced Solid Tumors
Interventions
DRUG

BMS-817378

Capsule, Oral, Dose escalation to a MTD from a starting dose of 25 mg, once daily, until disease progression/subject discontinuation

Trial Locations (3)

5000

Local Institution, Adelaide

6009

Local Institution, Nedlands

169610

Local Institution, Singapore

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY